DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. VFEND (voriconazole) Pf Prism Cv Patent number: 5,567,817 Expiration Date: May 24, 2016 DrugPatentWatch provides instant access to actionable insights on pharmaceutical drugs. For more information […]
DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. ZOFRAN (ondansetron hydrochloride) Novartis Pharms Corp Patent number: 5,854,270 Expiration Date: May 20, 2016 INVANZ (ertapenem sodium) Merck Sharp Dohme Patent number: 5,478,820 Expiration Date: May […]
This is a guest post from Susan K Finston, President of Finston Consulting. Do you have a response to Susan’s post? Respond in the comments section below. Warning: This next entry in the series: Biotech in Countries Starting with “I” is a ‘feel-good’ update on India’s new National Intellectual Property Rights Policy, released May 12, […]
DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. EPANOVA (omega-3-carboxylic acids) Astrazeneca Pharms Patent number: 5,948,818 Expiration Date: May 13, 2016 EPANOVA (omega-3-carboxylic acids) Astrazeneca Pharms Patent number: 5,792,795 Expiration Date: May 13, 2016 […]
DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. ASMANEX TWISTHALER (mometasone furoate) Merck Sharp Dohme Patent number: 5,829,434 Expiration Date: May 3, 2016 ZINGO (lidocaine hydrochloride) Powder Pharms Patent number: 5,899,880 Expiration Date: May […]
This is a guest post from Robert Yapundich, MD and Gregory Schimizzi, MD. Dr. Yapundich is a practicing neurologist in Hickory, North Carolina and a member of the Alliance for Patient Access. Dr Schimizzi is a practicing rheumatologist, treasurer of the Coalition of State Rheumatology Organizations and co-convener of the Biologics Prescribers Collaborative. Distinguishable biosimilar naming was the top issue for […]
DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. ELIDEL (pimecrolimus) Valeant Bermuda Patent number: 6,352,998 Expiration Date: Apr 26, 2016 ZORBTIVE (somatropin recombinant) Emd Serono Patent number: 5,898,030 Expiration Date: Apr 27, 2016 SEROSTIM […]
When do drug patents expire, and when can generic drugs launch? An overview of patents, non-patent regulatory exclusivities, and specific US and EU factors influencing generic drug launch.
DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. LASTACAFT (alcaftadine) Allergan Patent number: 5,468,743 Expiration Date: Apr 20, 2016 DrugPatentWatch provides instant access to actionable insights on pharmaceutical drugs. For more information try a […]
This is a guest post from Susan K Finston, President of Finston Consulting. Do you have a response to Susan’s post? Respond in the comments section below. Towards the end of 2015, I wrote about growing recognition of the importance of the microbiome for human health and consequently for commercial biopharmaceutical development here. Still microbiome research […]